Last reviewed · How we verify

NCT03719417

A Biologic Joint Replacement Strategy for Knee Trauma and Post-Traumatic Osteoarthritis

Completed NA Last updated 2 November 2022
What this trial tests

NA trial testing Unicompartmental Biologic Arthroplasty in Knee Osteoarthritis in 14 participants. Completed in 31 October 2022.

Timeline
1 December 2018
Primary endpoint
1 June 2022
31 October 2022

Quick facts

Lead sponsorUniversity of Missouri-Columbia
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment14
Start date1 December 2018
Primary completion1 June 2022
Estimated completion31 October 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Missouri-Columbia

Who can join

Adults 18 to 55, any sex, with Knee Osteoarthritis or Post-traumatic Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Participants will be enrolled in a prospective clinical trial to assess outcomes in 2 cohorts of patients undergoing unicompartmental versus more extensive biologic OCA transplantation of the knee using MOPSTM-preserved allografts (including menisci), anatomically-shaped allografts, autogenous bone marrow aspirate concentrate (BMC)-treated donor bone, and treatment-specific postoperative rehabilitation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The Current Status of Clinical Trials on Biologics for Cartilage Repair and Osteoarthritis Treatment: An Analysis of ClinicalTrials.gov Data.
    Zhang Z, Schon L. · · 2022 · cited 21× · PMID 35546280 · DOI 10.1177/19476035221093065

Verify or expand the search:

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

Other University of Missouri-Columbia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03719417.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing